ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

EUDA vs NAKA // FORWARD P/E MULTIPLE

EUDA Health Holdings Limited (NASDAQ) VS. Nakamoto Inc. (NASDAQ) • 15-METRIC TALLY: EUDA 6 — NAKA 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EUDA VS. NAKA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC EUDA NAKA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 43.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -31.60% -3.40 NAKA /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -5.39% -18.63% +13.24 EUDA /fcf-yield <GO>
Operating Margin -36.30% -60.00% +23.70 EUDA /operating-margins <GO>
Net Profit Margin -40.70% -60.00% +19.30 EUDA /net-margins <GO>
Revenue Growth (YoY) 70.00% -33.00% +103.00 EUDA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 EUDA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.7 33.9 +25.82 EUDA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $46.4M $126.2M -$79.8M NAKA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR EUDA REV NAKA REV EUDA GROSS % NAKA GROSS % EUDA FCF NAKA FCF
FY 2025 $6.8M $1.8M 43.9% — -$2.5M -$23.5M
FY 2024 $4.0M $2.7M 19.0% — -$2.1M -$3.1M
FY 2023 $3.7M $3.8M — — -$2.9M -$449.5K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EUDA // BETA —
NAKA // BETA —